CSC-Driven Resistance to Radiotherapy

Radiotherapy is a common treatment for cancer, but cancer stem cells (CSCs) are often resistant to radiation, leading to treatment failure and tumor recurrence. This track investigates the mechanisms by which CSCs resist radiotherapy, including enhanced DNA repair, activation of survival pathways, and antioxidant defenses. Researchers explore strategies to sensitize CSCs to radiation by targeting these resistance mechanisms, improving the overall effectiveness of radiotherapy. By overcoming CSC-driven radioresistance, this research aims to reduce the likelihood of cancer recurrence and improve patient survival rates. This track highlights the importance of developing combination therapies that target CSCs to enhance the success of radiotherapy.

    Related Conference of CSC-Driven Resistance to Radiotherapy

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    CSC-Driven Resistance to Radiotherapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in